TXNIP and Alzheimer disease: What’s more, miR-16-5p has been shown to be decreased in AD (Gui et al., 2015), and MiR-16-5p targets TXNIP to regulate LPS-induced oxidative stress and apoptosis in cardiomyocytes (Yu-Cheng et al., 2020).